Weaker immunity hinders RSV vaccine response

This is a M.D. news story, published by ScienceDaily, that relates primarily to Dorry Segev news.

M.D. news

For more M.D. news, you can click here:

more M.D. news

Dorry Segev news

For more Dorry Segev news, you can click here:

more Dorry Segev news

biology news

For more biology news, you can click here:

more biology news

ScienceDaily news

For more news from ScienceDaily, you can click here:

more news from ScienceDaily

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about

RSV vaccine responses

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Respiratory Syncytial Virus Vaccination news, RSV vaccine news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

RSV vaccines

ScienceDaily

•

People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination

Summary

Nutrition label

81% Informative

People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination.

Johns Hopkins Medicine says further research is needed to better understand the problem and find ways to enhance immune response in this high-risk population.

RSV is a contagious pathogen that causes infections of the respiratory tract.

CDC recommends that everyone 75 and older receive a single dose of an RSV vaccine.

CDC recommends people who are immunocompromised in groups at high risk of infection by the virus.

Study co-authors include Dorry Segev , M.D. , Ph.D. from New York University Grossman School of Medicine .

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity